Cabazitaxel injection (Beihai Biotech)

N/A

Report date: 2026/02/18 20:02:09

Base Information

Drug NameCabazitaxel injection (Beihai Biotech)
Drug Alias NameBH-002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTubulin inhibitorsTubulin polymerisation promoters
TargetsTubulin
Therapy Area/IndicationsSolid tumoursProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsSolid tumoursProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A